Established in 2007, Ningbo Dekang Biological Products Co., Ltd. is a technology-driven enterprise specializing in R&D, production and sales of biological and natural animal and plant related products. At present, it has developed dozens of products in several series of meal replacement powder, substitute tea, compressed candy, solid beverage and cream. It has registered more than 100 trademarks and established cooperative relationships with many large enterprises.

More than 50% of Dekang Bio-Employees are Bachelor degree or above in Pharmacy, Food Engineering, Biochemistry, and Shenyang University of Pharmaceutical Sciences, China Pharmaceutical University, Zhejiang Pharmaceutical College, Nanchang University, Xiamen Pharmaceutical University, Zhejiang University Ningbo Institute of Technology Experts and professors from well-known universities have established long-term cooperative R&D relationships, focusing on industrial and commercial transformation of innovative health products.

The company focused on the development of natural products in the early days, providing high-tech plant active ingredients for the international market, with a variety of 300 varieties, including paclitaxel, artemisinin, ginkgo flavonoids, myricetin and other high-efficiency pharmacological active substances; the company is committed to the modernization of traditional Chinese medicine, the company It is the pioneer of traditional Chinese medicine modernization, the earliest promotion of traditional Chinese medicine formula granules to the international market. The products are exported to Europe, the United States, Japan and Southeast Asia.

With the advent of China's aging society, in recent years, the development of Chinese medicine has received strong support from the Party Central Committee and the State Council. The Chinese medicine major health industry will become an important task for healthy China. A series of policies, such as the Chinese Medicine Law of the People's Republic of China and the Outline of the Strategic Plan for the Development of Traditional Chinese Medicine 2016-2030, have introduced the development of the Chinese medicine industry to the national strategy. The development of Chinese medicine major health industry has legal guarantee and policy support, which has defined the direction and key points for the future development of Chinese medicine health and health products. The large health industry based on nutrition and health has become a sunrise industry.

From natural health raw materials to finished products, Ningbo Dekang has more than 100 foreign customers and more than 100 domestic customers, establishing a long-term cooperative relationship.

The company's existing five production lines are all in the process of ingredients, preparations and packaging. The processes involving high energy consumption and low added value are completed by means of OEM, and gradually become the big sales and development of universities + enterprises, and the sales of brands + channels. Small production incubation of the process + mode of large production outsourcing.